Strategy Comparison. Financial Review. In Appendix A you will find the total roll up of the financial and marketing data that shows all three strategies side by side. In Appendix A1, you will find the financial data and graphs to show the visual differences on a graphical line chart. X5. Tablet. Careful review of the financial information on the X5 has shown there to be an increase in its profitability as an indication of profitable increases in 2011 from 16% to 30% in 2012. Despite the pricing being set at $285, the X5 has relatively high fixed costs of $75,000,000. There are indications that there are still gains of profitability and growth, this product has reached or reaching its product lifecycle due to being in the relative markets for 3 years. Indications that their will need
…show more content…
There are indications that expected sales for the X6, are prevalent for this product as it is currently in the growth aspects of the product lifecycle. There are also indications that the X6 is better than the current competitor’s products and there for be likely for repeat sales of our customers based on the performance factors. Although this product has only been on the market for a 2-year period. It is also likely that this will reach its maturity level in its product lifecycle. Which will most likely occur as an indication when the X5 begins to meet that level of maturity most likely in 2015 as indicated in Appendix A1. X7 Tablet. This product being relatively new on the market and its given low price point will attract future customers and help to grow the brand and market saturation with our products. This product is on the growth aspect of the product lifecycle. There will likely be no repeat sales of the X7 as it’s a relatively new product currently. It is likely that this will be our product that attracts majority of the untapped market consumers. Given the price point, features and relatively cheap cost associated and compared to our
There are indications that expected sales for the X6, are prevalent for this product as it is currently in the growth aspects of the product lifecycle. There are also indications that the X6 is better than the current competitor’s products and there for be likely for repeat sales of our customers based on the performance factors. Although this product has only been on the market for a 2-year period. It is also likely that this will reach its maturity level in its product lifecycle. Which will most likely occur as an indication when the X5 begins to meet that level of maturity most likely in 2015 as indicated in Appendix A1. X7 Tablet. This product being relatively new on the market and its given low price point will attract future customers and help to grow the brand and market saturation with our products. This product is on the growth aspect of the product lifecycle. There will likely be no repeat sales of the X7 as it’s a relatively new product currently. It is likely that this will be our product that attracts majority of the untapped market consumers. Given the price point, features and relatively cheap cost associated and compared to our